2nd Annual TGF-β for Immuno-Oncology Drug Development

Tuesday, January 25th – Thursday, January 27th

Digital Event:
Click here for access

Overview:

Outcome’s Dr. John Armstrong will be providing An Overview of the TGF-β IO Market including:

Current approaches in the TGF-β IO market
Recent M&A, equity financing, and strategic partnership transactions in the TGF- β IO market
How to position your company, team, and asset for a successful entry into the TGF-β IO market

For more information, please contact jarmstrong@outcomecapital.com

Resources April 15, 2025

A Shifting Market Environment and Strategies Fueling Innovation in Prostate Cancer Treatment

Blockbuster drug patent expiration, advances in enabling technology, and the emergence of personalized medicine for prostate cancer treatment create a landscape worth examining.

Download

Resources March 2025

Outcome Capital Life Science Market Pulse, March 2025

Outcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter

Download

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?